Literature DB >> 11134351

A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1.

A K Ghosh1, M Majumder, R Steele, R A White, R B Ray.   

Abstract

We initially identified c-myc promoter-binding protein 1 (MBP-1) from a human cervical carcinoma cell expression library which negatively regulates c-myc promoter activity. A recent study demonstrated that MBP-1 acts as a general transcriptional repressor (A. K. Ghosh, R. Steele, and R. B. Ray, Mol. Cell. Biol. 19:2880-2886, 1999). In order to identify the cellular protein(s) interacting with MBP-1 for transcriptional regulation, a HeLa cell cDNA expression library was screened using a yeast two-hybrid system. An MBP-1-interacting cDNA encoding a polypeptide of 140 amino acid residues with an approximate molecular mass of 16 kDa was identified and named MBP-1 interacting protein-2A (MIP-2A). MIP-2A has a sequence similarity with an unknown mRNA and SEDL. Mutations in the SEDL gene, located at human chromosome Xp22, has recently been implicated with an X-linked genetic disease, although the function of SEDL gene product was not determined (A. K. Gedeon et al., Nat. Genet. 22:400-404, 1999). However, our results suggested the localization of MIP-2A at human chromosome 19. The specificity of interaction between MBP-1 and MIP-2A was verified by an in vitro glutathione S-transferase pulldown experiment, a mammalian two-hybrid analysis, and in vivo coimmunoprecipitation assays. Further analysis revealed that the amino-terminal domain of MBP-1 (amino acids 1 to 95) interacts with MIP-2A. Immunofluorescent staining suggested colocalization of MIP-2A and MBP-1 primarily in the perinuclear membrane of cells. Functional analysis demonstrated that MIP-2A relieves MBP-1 mediated transcriptional repression on c-myc promoter. Additionally, MIP-2A antagonizes cell growth regulatory role of MBP-1. Taken together, these results suggest the functional interaction of MIP-2A and MBP-1 in cell growth regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134351      PMCID: PMC86643          DOI: 10.1128/MCB.21.2.655-662.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.

Authors:  X Y Yin; K Gupta; W P Han; E S Levitan; E V Prochownik
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

Review 2.  Active repression mechanisms of eukaryotic transcription repressors.

Authors:  W Hanna-Rose; U Hansen
Journal:  Trends Genet       Date:  1996-06       Impact factor: 11.639

3.  The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter.

Authors:  D Chaudhary; D M Miller
Journal:  Biochemistry       Date:  1995-03-14       Impact factor: 3.162

Review 4.  Repression versus activation in the control of gene transcription.

Authors:  I G Cowell
Journal:  Trends Biochem Sci       Date:  1994-01       Impact factor: 13.807

5.  Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda.

Authors:  A K Gedeon; A Colley; R Jamieson; E M Thompson; J Rogers; D Sillence; G E Tiller; J C Mulley; J Gécz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

6.  The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression.

Authors:  X Yu; L C Wu; A M Bowcock; A Aronheim; R Baer
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

7.  MBP-1 physically associates with histone deacetylase for transcriptional repression.

Authors:  A K Ghosh; R Steele; R B Ray
Journal:  Biochem Biophys Res Commun       Date:  1999-07-05       Impact factor: 3.575

8.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.

Authors:  B Amati; S Dalton; M W Brooks; T D Littlewood; G I Evan; H Land
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

9.  Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.

Authors:  G Meroni; A Reymond; M Alcalay; G Borsani; A Tanigami; R Tonlorenzi; C Lo Nigro; S Messali; M Zollo; D H Ledbetter; R Brent; A Ballabio; R Carrozzo
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

10.  Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.

Authors:  P J Hurlin; C Quéva; P J Koskinen; E Steingrímsson; D E Ayer; N G Copeland; N A Jenkins; R N Eisenman
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  10 in total

1.  Evolutionary fate of retroposed gene copies in the human genome.

Authors:  Nicolas Vinckenbosch; Isabelle Dupanloup; Henrik Kaessmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

2.  MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2.

Authors:  Kai-Wen Hsu; Rong-Hong Hsieh; Chew-Wun Wu; Chin-Wen Chi; Yan-Hwa Wu Lee; Min-Liang Kuo; Kou-Juey Wu; Tien-Shun Yeh
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

Review 3.  The TRAPP complex: insights into its architecture and function.

Authors:  Michael Sacher; Yeon-Gil Kim; Arnon Lavie; Byung-Ha Oh; Nava Segev
Journal:  Traffic       Date:  2008-10-14       Impact factor: 6.215

4.  Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.

Authors:  Mariavera Lo Presti; Arianna Ferro; Flavia Contino; Claudia Mazzarella; Silvia Sbacchi; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Paola Migliorini; Antonio Marrazzo; Salvatore Feo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

5.  trappc11 is required for protein glycosylation in zebrafish and humans.

Authors:  Charles DeRossi; Ana Vacaru; Ruhina Rafiq; Ayca Cinaroglu; Dru Imrie; Shikha Nayar; Anastasia Baryshnikova; Miroslav P Milev; Daniela Stanga; Dhara Kadakia; Ningguo Gao; Jaime Chu; Hudson H Freeze; Mark A Lehrman; Michael Sacher; Kirsten C Sadler
Journal:  Mol Biol Cell       Date:  2016-02-24       Impact factor: 4.138

6.  Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.

Authors:  Patrizia Cancemi; Miriam Buttacavoli; Elena Roz; Salvatore Feo
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

7.  SEDLIN forms homodimers: characterisation of SEDLIN mutations and their interactions with transcription factors MBP1, PITX1 and SF1.

Authors:  Jeshmi Jeyabalan; M Andrew Nesbit; Juris Galvanovskis; Richard Callaghan; Patrik Rorsman; Rajesh V Thakker
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

8.  Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer.

Authors:  Flavia Contino; Claudia Mazzarella; Arianna Ferro; Mariavera Lo Presti; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Salvatore Feo
Journal:  BMC Cancer       Date:  2013-02-19       Impact factor: 4.430

9.  TRAMM/TrappC12 plays a role in chromosome congression, kinetochore stability, and CENP-E recruitment.

Authors:  Miroslav P Milev; Benedeta Hasaj; Djenann Saint-Dic; Sary Snounou; Qingchuan Zhao; Michael Sacher
Journal:  J Cell Biol       Date:  2015-04-27       Impact factor: 10.539

10.  MIP-2A is a novel target of an anilinoquinazoline derivative for inhibition of tumour cell proliferation.

Authors:  Mayuko Tokunaga; Hirokazu Shiheido; Noriko Tabata; Yuko Sakuma-Yonemura; Hideaki Takashima; Kenichi Horisawa; Nobuhide Doi; Hiroshi Yanagawa
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.